KIORA PHARMACEUTICALS INC Annual Net Income (Loss) Attributable to Parent in USD from 2017 to 2023

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Kiora Pharmaceuticals Inc quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2017 to 2023.
  • Kiora Pharmaceuticals Inc Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$3.41M, a 40.8% increase year-over-year.
  • Kiora Pharmaceuticals Inc Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was $5.55M.
  • Kiora Pharmaceuticals Inc annual Net Income (Loss) Attributable to Parent for 2023 was -$12.5M, a 7.88% increase from 2022.
  • Kiora Pharmaceuticals Inc annual Net Income (Loss) Attributable to Parent for 2022 was -$13.6M, a 1.36% increase from 2021.
  • Kiora Pharmaceuticals Inc annual Net Income (Loss) Attributable to Parent for 2021 was -$13.8M, a 101% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$12.5M +$1.07M +7.88% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-25
2022 -$13.6M +$187K +1.36% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-25
2021 -$13.8M -$6.91M -101% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-23
2020 -$6.86M +$235K +3.31% Jan 1, 2020 Dec 31, 2020 10-K/A 2022-07-07
2019 -$7.1M +$3.71M +34.4% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-25
2018 -$10.8M +$2.41M +18.2% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-04
2017 -$13.2M Jan 1, 2017 Dec 31, 2017 10-K 2019-03-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.